1. Eight Cycles of Neoadjuvant Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Versus Four Cycles of Perioperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Locally Advanced, Resectable Gastric or Gastroesophageal Adenocarcinoma (FLOT8): A Multicenter, Randomized, Phase II Clinical Trial, Ongoing, Writing the Protocol
2. A Phase II Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Adjuvant Lenvatinib in High-Risk Hepatocellular Carcinoma (HCC) Patients Following Liver Transplantation (SECURE-HCC Trial), Ongoing, Writing the Protocol.
3. Molecular Landscape and Survival Outcomes Associated with Specific KRAS Codon Mutations in Advanced Colorectal Cancer, Retrospective Analysis, Foundation Medicine, Ongoing, Data Processing.
4. Molecular and Immune Markers Landscape of ARID1A Mutation in Gastric Cancer, Retrospective Analysis, Foundation Medicine, Ongoing, Data processing.
5. Safety and Efficacy of Lenvatinib as Second line Treatment Post-Immunotherapy: A Systematic Review & Meta-Analysis, Ongoing, Data Analysis
6. The Role of Staging Laparoscopy for the Detection of Peritoneal Metastasis: A Systematic Review and Meta-Analysis, Ongoing, Data Analysis
Hamed Alhusseini, MBBS
Acting Chairman, Medical Oncology Department
Cancer Center of Excellence
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Contact: Hhusseini@kfshrc.edu.sa
Ahmed Alzahrani, MBBS
Program Director, Medical Oncology Fellowship
Cancer Center of Excellence
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Contact: Aalzahrani@kfshrc.edu.sa
Ali Alqahtani, MD
Consultant, Medical Oncology Department
Cancer Center of Excellence
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Contact: AliAlqahtani@kfshrc.edu.sa